ChartRow logo
HRMY
$38.70+3.09%
as of close, Oct 20, 2026
☾ AH $38.70 +3.09%
PeersMRNALLYMDTUNHJNJTMO
Share this page

Harmony Biosciences Holdings Inc. trailing returns

How Harmony Biosciences Holdings Inc. (HRMY) has performed over the last day, week, month and year, over 5 years, and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day+3.1%+0.0%+3.1%—
5 days+4.5%+0.0%+4.5%-1.9%Oct 19
1 month-7.9%+0.0%-7.9%-12.0%Oct 13
YTD+3.4%+0.0%+3.4%-31.2%Mar 27
1 year+48.7%+0.0%+48.7%-34.5%Mar 2026
5 years-1.6%+0.0%-1.6%-7.8%-68.5%Oct 2023
Since inception (2020)+0.7%+0.0%+0.7%+4.6%-68.5%Oct 2023

Growth of HRMY#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years-1.6%/year · -7.8%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in HRMY's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Harmony Biosciences Holdings Inc.'s return since inception?
Since 2020, Harmony Biosciences Holdings Inc. (HRMY) has compounded at about +0.7% a year — +4.6% in total.

More on Harmony Biosciences Holdings Inc.